Terapia de mantenimiento con inhibidores de PARP en cáncer de ovario: Un nuevo concepto para aumentar la supervivencia en la enfermedad recurrente

PARP inhibitors as maintenance in ovarian cancer relapse

Agenda

•

Biomarkers and development of PARPi in ovarian cancer

•

Overview of efficacy outcomes by biomarkers cohorts

•

Long-term benefit

•

Safety profile and quality of life

•

Future of PARP inhibitors as maintenance in recurrence setting